AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 251 min read

AJB Investment Fund II, LP (Bradley Adam James, Bradley Melinda Hodges) purchased $19K of JCTC (indirect holdings)

AJB Investment Fund II, LP purchased 6,342 indirectly-held shares of JEWETT CAMERON TRADING CO LTD (JCTC) at an average of $2.92 ($2.90–$2.94) across 4 trades over 2026-09-23 to 2026-09-25. Filed jointly with AJB Capital, LLC (10% owner), Bradley Adam James (10% owner) and Bradley Melinda Hodges (10% owner).

Original reporting
SEC EDGAR · AJB Investment Fund II, LP, AJB Capital, LLC, Bradley Adam James, Bradley Melinda Hodges
Published Sep 25, 2026, 9:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction is modest ($19K) and unlikely to move the stock price; it simply updates the ownership record.

02

Market read

Minor insider purchase with limited trading relevance.

03

What to watch

none

Relevance 3/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses a small open‑market purchase by an investment fund of shares in Jewett Cameron Trading Co Ltd.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

none

Key entities

  • issuer
    Jewett Cameron Trading Co Ltd

    Company whose shares were purchased.

  • insider
    AJB Investment Fund II, LP

    Reporting entity acquiring the shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JCTC insider trading history →

Related articles

OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min